Coherus BioSciences Inc. (Coherus) is a late-stage clinical biologics platform Company. The Company is focused on delivering biosimilar therapeutics. Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The Company has worked on approximately 100 molecules, developed and manufactured around 14 products and launched approximately 30 products across the world. Coherus’ is in partnerships include global pharmaceutical companies in Europe, Asia and Latin America.